No products in the cart.
MODULE 11: PATIENT ADHERENCE & PERSISTENCY
Section 11.1: Barriers to Adherence in Specialty Populations
A deep dive into the complex web of factors—clinical, financial, logistical, psychosocial, and behavioral—that cause patients to deviate from or discontinue specialty therapies.
SECTION 11.1
Barriers to Adherence in Specialty Populations
From Clinical Detective to Frontline Responder: The Pharmacist’s Role in a Code Sepsis.
11.1.1 The “Why”: Deconstructing the Specialty Adherence Challenge
In your community pharmacy career, you have been a frontline soldier in the battle for medication adherence. You have counseled on the importance of taking lisinopril daily, you have helped patients remember their metformin, and you have wrestled with $10 copays. Your skill in this area is foundational. Now, as an advanced specialty pharmacist, you are being asked to elevate that skill to an entirely new theater of operations.
Adherence in the specialty world is not just more difficult; it is fundamentally different. The stakes are higher, the costs are astronomical, the logistics are labyrinthine, and the reasons for non-adherence are a complex, interconnected web of clinical, financial, and emotional challenges. A single missed dose of a transplant medication isn’t just a “gap in therapy”; it’s a potential trigger for acute organ rejection. A “vacation from” a biologic for rheumatoid arthritis isn’t just a pause; it’s an invitation for the body to develop neutralizing antibodies, rendering a $70,000-per-year drug useless forever.
Your role as a specialty pharmacist is to transform from a “dispenser” into a “detective” and “problem-solver.” You are no longer just asking if the patient is taking their medication; you are proactively investigating why they might stop. This section is your guide to deconstructing that complex web. We will provide you with the framework to identify, categorize, and, most importantly, solve the barriers that stand between your patient and a life-changing therapy.
Clearing the Language: Adherence vs. Compliance vs. Persistence
In specialty, words matter. They shape our approach to patient care. Your community experience may have used these terms interchangeably, but a CASP pharmacist must be precise.
| Term | Definition | Clinical Question It Answers | Why the Distinction Matters |
|---|---|---|---|
| Compliance | A paternalistic, outdated term implying a patient’s passive “obedience” to a prescriber’s orders. | “Is the patient doing what they were told?” | We avoid this term. It frames the patient as “non-compliant” or “disobedient,” which assigns blame. It ignores the patient’s role as a partner in their own care. |
| Adherence | The extent to which a patient’s behavior (e.g., taking medication, following a diet) corresponds with agreed-upon recommendations from a healthcare provider. | “Is the patient taking their medication correctly as prescribed?” (e.g., 80% of the time, 90% of the time) | This is the modern, collaborative term. It implies a partnership (“agreed-upon”). It is the focus of metrics like MPR and PDC (which we will cover in Section 11.5). It measures implementation. |
| Persistence | The duration of time from initiation to discontinuation of a therapy. | “Is the patient still on the medication after 6 months? 12 months?” | This is a critical, distinct metric in specialty. A patient can be 100% adherent for three months and then discontinue therapy (making them non-persistent). Non-persistence is often the bigger problem. Our job is to promote both. |
Your new mission is to identify barriers to both adherence (e.g., a patient who only injects Humira once a month instead of every two weeks) and persistence (e.g., a patient who stops Otezla completely after two months due to side effects).
Pharmacist Analogy: The $10 Pothole vs. The 5-Car Pileup
In your community practice, non-adherence was often like a $10 pothole. A patient doesn’t pick up their lisinopril. You call them. “Oh, I forgot,” they say, “and I didn’t feel like dealing with the $10 copay.” The barrier is simple (forgetfulness, low cost) and the fix is straightforward (a reminder call, a discount card). The consequence is long-term (a future risk).
In specialty pharmacy, non-adherence is a 5-car pileup in the fog. Your patient on a $5,000/month biologic for Crohn’s disease misses a shipment. When you call, you don’t find a simple pothole. You find a catastrophic, multi-vehicle disaster.
- Car 1 (Financial): The patient hit their “Donut Hole” and the copay jumped from $50 to $1,500. They were too embarrassed to say anything.
- Car 2 (Logistical): The insurance company changed its preferred specialty pharmacy, so your fill was rejected, but no one told the patient.
- Car 3 (Clinical): The patient has been “pre-treating” with Benadryl for injection site reactions that have gotten worse, but they didn’t want to “bother” the doctor.
- Car 4 (Psychosocial): The patient is overwhelmed with depression from their chronic illness and simply doesn’t have the energy to fight the insurance company (Car 2) about the copay (Car 1).
- Car 5 (Behavioral): Their uncle told them he saw something on social media about biologics causing cancer, so the patient figured this “was a sign” to stop the drug.
Your job as a CASP pharmacist is not just to fix the pothole. Your job is to be the first responder on the scene of the pileup. You must triage the disaster, investigate each barrier, and coordinate a multi-pronged solution: You (1) call the PAN Foundation to get a grant for the copay, (2) call the prescriber to transfer the prescription to the new pharmacy, (3) counsel the patient on switching from Benadryl to Claritin and using hydrocortisone cream *after* the injection, not before, (4) connect the patient with a nurse case manager for their depression, and (5) use the “teach-back” method to explain the *real* risk/benefit data vs. social media misinformation.
This is specialty adherence. It’s high-stakes, complex investigation, and total problem-solving. This module is your investigative playbook.
11.1.2 The Five Pillars of Non-Adherence: A Framework for Investigation
To untangle the 5-car pileup, you need a framework. The World Health Organization (WHO) provides the industry-standard model, which we have adapted for specialty pharmacy. Every barrier to adherence can be sorted into one of these five “pillars” or “domains.” When a patient is non-adherent, your job is to mentally (or literally) go through this checklist to find the root cause(s).
1. Clinical Barriers
Related to the disease and the drug itself (e.g., side effects, needle phobia, complex dosing).
2. Financial Barriers
Related to the cost of the therapy (e.g., high copays, deductibles, coinsurance).
3. Logistical Barriers
Related to the system of access (e.g., prior authorization, cold chain, REMS).
4. Psychosocial Barriers
Related to the patient’s mind and environment (e.g., depression, social stigma, lack of support).
5. Behavioral Barriers
Related to the patient’s beliefs and knowledge (e.g., health literacy, misinformation, forgetfulness).
Over the next five masterclass sections, we will perform a deep dive into each of these pillars, providing you with the questions, playbooks, and solutions to become an expert adherence investigator.
11.1.3 Masterclass: Deconstructing Clinical Barriers
Clinical barriers are problems that arise directly from the disease state or the medication itself. This is often the most significant driver of non-persistence in the first 90 days of therapy. If a drug makes a patient feel sick, they will stop taking it. Your community pharmacy experience has prepared you for this, but specialty side effects are often more complex and require a proactive, high-touch management plan.
Barrier 1.1: Side Effects and Adverse Drug Events (ADEs)
This is the number one reason for non-persistence. In traditional pharmacy, side effects are often a nuisance (e.g., statin-induced myalgia, ACE-inhibitor cough). In specialty, they can be debilitating and terrifying. Our job is not just to warn patients; it is to normalize the manageable side effects and triage the dangerous ones.
Proactive vs. Reactive Counseling:
– Reactive (The Old Way): “Call your doctor if you experience nausea, diarrhea, or headache.” (The patient is left alone to figure it out).
– Proactive (The CASP Way): “When you start this medication, many patients experience [side effect] in the first two weeks. This is a normal sign that your body is adjusting to the drug. Here is our 3-step plan for managing it…”
Pharmacist Playbook: The Proactive Side Effect Onboarding Script
This script, used during the initial adherence call, is your most powerful tool. Let’s use the example of Apremilast (Otezla) for psoriasis, which is notorious for causing GI upset and headache in the first few weeks.
“Hi Mr. Smith, this is [Your Name], your specialty pharmacist. I’m calling as part of our Otezla Onboarding Program. I see you’re about to start your 14-day titration pack. I want to spend two minutes setting you up for success, because this medication works fantastically, but the first two weeks can be a bit tricky. Is now a good time?”
1. Normalize & Set Expectations: “As your body gets used to the medication, it is very common to experience some nausea, an upset stomach, or maybe a headache. The most important thing to know is that for over 90% of patients, this goes away completely by week 3 or 4. It is not permanent.”
2. Provide the Plan: “We have a two-part plan for this.
First, always take your Otezla with food. Never on an empty stomach. Taking it with your breakfast and dinner is the best way to prevent nausea.
Second, if you still feel some nausea, an over-the-counter medication like Emetrol or even a cup of strong ginger tea can be very helpful. For headaches, Tylenol is perfectly safe to use.”
3. Create the “Safety Net”: “My job is to be your partner through this. I am going to call you back in 7 days, just to see how you’re handling that titration. If the side effects are bothering you, do not stop the drug. Call me first. We have other tricks, like slowing down the titration, that we can discuss with your doctor. My direct line is…”
Masterclass Table: Proactive Management of Common Specialty ADEs
| Drug Class / Example | Common “Persistence-Killing” ADE | The CASP Pharmacist’s Proactive Management Plan |
|---|---|---|
| Interferons (e.g., Avonex, Rebif) (Multiple Sclerosis) |
Injection-site reactions (ISRs) and debilitating flu-like symptoms (fever, chills, myalgia) 6-8 hours post-injection. |
|
| SGLT2 Inhibitors (e.g., Farxiga, Jardiance) (HFrEF, CKD) |
Genitourinary yeast infections (vulvovaginal candidiasis, balanitis). Dizziness from osmotic diuresis. |
|
| Dimethyl Fumarate (Tecfidera) (Multiple Sclerosis) |
Flushing (aspirin-mediated) and severe GI distress (nausea, cramping, diarrhea). |
|
| GLP-1 Agonists (e.g., Ozempic, Trulicity) (Diabetes, Obesity) |
Nausea, vomiting, constipation, and “sulfur burps.” |
|
Barrier 1.2: Fear of Self-Injection (Needle Phobia)
Many of the most effective specialty drugs—biologics for RA, Crohn’s, Psoriasis, and MS—are injectables. For a patient who has never given themselves a shot, this is a terrifying emotional and physical hurdle. You cannot simply mail them a box of syringes and a “how-to” pamphlet. This barrier requires empathy, training, and building confidence.
Pharmacist Tutorial: The “First Dose Teach” (Virtual or In-Person)
This is a core competency of a specialty pharmacist. Whether you do this in a private room or over a video call, the steps are the same. This is your chance to build a relationship that will last for years.
Preparation: Have your “teach kit” ready: a training injector pen (most manufacturers provide these), alcohol swabs, a sharps container, and a “dummy” to inject into (like a foam block or citrus fruit).
- Step 1: Empathize & Normalize.
Script: “First, let’s acknowledge that this is weird. Nobody likes needles, and the idea of giving yourself a shot is strange. My job for the next 15 minutes is to make this as boring and routine as brushing your teeth. I’ve trained hundreds of patients who were just as nervous as you, and they are all pros now. You will be, too.” - Step 2: “I Do” (Demonstration).
Script: “I’m going to show you the whole process with this training pen. It has no needle and no medicine. I’m just going to show you the steps.
1. First, we take it out of the fridge and let it sit for 30 minutes. This is the most important tip. Injecting cold medicine stings. Room-temp medicine doesn’t.
2. Second, we pick our spot. We can use the stomach (avoiding 2 inches around the belly button) or the top of the thighs. We will rotate this spot every single time.
3. Third, we clean the site with an alcohol swab and let it dry.
4. Fourth, we take off the cap.
5. Fifth, we press it firmly against the skin—so firmly that the gray part disappears. Then, we press the button. We’ll hear a ‘CLICK’.
6. Sixth, we hold it for 10 seconds. 1…2…3…10. We wait for the second ‘CLICK’ (or for the window to turn yellow).
7. Seventh, we’re done. We lift it up, and the needle is already covered. We put it straight into the sharps container. See? Simple.” - Step 3: “We Do” (Guided Practice).
Script: “Okay, now it’s your turn. I want you to take the training pen and walk me through those exact same steps on our foam block here. I’ll be quiet and just watch.”
(Patient practices. You correct them gently. “That’s perfect. Next time, just make sure you press it a little more firmly before you hit the button. You got this.”) - Step 4: “You Do” (The First Dose or “Homework”).
Script (if in person): “You did great. You are ready. Now, you have two choices. We can do the real injection right here, right now, together. Or, you can take your pen home and do it tonight. There is no wrong answer.”
Script (if virtual): “You’re a pro. Your ‘homework’ is to do your first injection tonight. When you do it, remember: 30 minutes out of the fridge, clean the spot, press firmly, click, hold for 10. You’ve got this. I’m going to call you tomorrow just to hear you say ‘I did it.'”
Barrier 1.3: Complex Regimens and Pill Burden
Not all specialty drugs are biologics. Many, like oral oncology agents or drugs for pulmonary arterial hypertension (PAH), have incredibly complex dosing schedules, titration packs, and a high pill burden that can be confusing and overwhelming for patients. This “cognitive load” is a massive adherence barrier.
Examples of Complexity:
– Titration Packs: Otezla (14-day pack), Tecfidera (14-day pack), Gilenya (requires 6-hour first-dose observation for bradycardia).
– High Pill Burden: Trikafta for Cystic Fibrosis (2 tablets in AM, 1 in PM, *must* be taken with high-fat food), Nintedanib for IPF (1 capsule q12h *exactly* 12 hours apart).
– Complicated Administration: Creon for CF (dosed based on grams of fat in a meal, must be taken *with* the first bite), inhaled antibiotics (e.g., Cayston, must be taken 3x/day at least 4 hours apart, *cannot* be mixed with other nebulized drugs).
Pharmacist Playbook: The “Adherence Map”
When a patient is on a complex regimen, you must become their “navigator.” Do not rely on the instructions on the vial. You must create a custom “Adherence Map” or “Medication Calendar.”
Case Study: A patient is starting Trikafta (2 tabs AM, 1 tab PM, with fat) and also takes Creon (dosed per meal), an inhaled antibiotic (Tobi Podhaler, 2 capsules BID), and does airway clearance (chest vest) twice a day.
The Pharmacist’s Solution: You create a single, laminated sheet for their fridge:
YOUR DAILY MAP:
MORNING (e.g., 8:00 AM)
Before Breakfast: Airway Clearance (Chest Vest) – 20 min
With Your First Bite of Breakfast (must contain fat like eggs, avocado, or full-fat yogurt):
Take 2 ORANGE (Trikafta) tablets.
Take [X] capsules of CREON.
After Breakfast: Inhale TOBI PODHALER.
EVENING (e.g., 8:00 PM – 12 hours later)
With Your First Bite of Dinner/Snack (must contain fat like cheese, nuts, or ice cream):
Take 1 BLUE (Trikafta) tablet.
Take [X] capsules of CREON.
Before Bed: Airway Clearance (Chest Vest) – 20 min
After Airway Clearance: Inhale TOBI PODHALER.
This simple, visual tool transforms a confusing list of commands into a clear, manageable daily routine. This is a high-value, high-impact pharmacist intervention.
Barrier 1.4: Asymptomatic or “Silent” Disease States
This is a profound psychological barrier. Why would a patient take a $5,000/month drug that causes side effects to treat a disease they can’t feel? This is common in many specialty conditions:
- Multiple Sclerosis: In a relapsing-remitting state, the patient feels 100% normal. The purpose of their injectable is to prevent a future relapse, not to treat a current symptom.
- HIV: A patient with an undetectable viral load feels healthy. They stop their ART regimen for a week, feel no different, and think, “I’m cured, I don’t need this.” They don’t feel the virus roaring back to life.
- Post-Transplant: A kidney transplant recipient feels fantastic—better than they have in years. They don’t “feel” their immune system slowly building an attack against their new organ. Stopping their tacrolimus is a silent, fatal error.
Pharmacist Playbook: Making the Invisible, Visible
When the disease is silent, your job is to give the patient a visible metric to connect their adherence to. You must change their “why” from “I take this so I don’t feel sick” to “I take this to control my [metric].”
For the MS Patient:
Script: “I know it is incredibly hard to take a shot every week when you feel perfectly fine. But this drug isn’t for today. It’s for your future. Your ‘why’ for taking this isn’t about symptoms; it’s about your next MRI. Our goal is ‘No New Lesions.’ Every shot you take is you fighting to keep that next MRI scan clear. That’s our victory.”
For the HIV Patient:
Script: “The reason you feel so healthy is because this medication is doing its job perfectly. It has your viral load down to ‘undetectable.’ That’s our goal, and you’ve achieved it! But ‘undetectable’ doesn’t mean ‘gone.’ The virus is just sleeping. Our job, together, is to keep it sleeping. Every single dose you take is what keeps that number at ‘undetectable’ and keeps you healthy.”
For the Transplant Patient:
Script: “This tacrolimus is the most important medication you will ever take. It’s the ‘food and water’ for your new kidney. You can’t feel your immune system, but we can measure it. Your ‘why’ for taking this is your tacrolimus trough level. Our goal is to keep that level perfectly between 5 and 8. Every dose, twice a day, on time, is how we protect that new organ. Your job is the dose; my job is to watch that lab level with you.”
11.1.4 Masterclass: Deconstructing Financial Barriers
Financial barriers (or “financial toxicity”) are the single greatest challenge in specialty pharmacy. This is the #1 reason for persistence failures after the first 90 days. In community pharmacy, you dealt with $10-$50 copays. In specialty, you will be solving for $2,500 coinsurance, $8,000 deductibles, and six-figure “sticker prices.”
Your role as a specialty pharmacist is to be a forensic financial investigator and resource navigator. You must be able to instantly triage a patient’s financial situation and know *exactly* which tool to use to solve it. Failure here means the patient never even *starts* the therapy (a “first-fill non-adherence”).
Barrier 2.1: The Landscape of Cost-Share
You must become fluent in the mechanisms of patient cost-share. This is the “enemy” you are fighting.
- The Sticker Price: The “Wholesale Acquisition Cost” (WAC) of the drug. This is the undiscounted price, e.g., $70,000 per year for Humira. This is what the patient sees on the EOB and panics, even if they don’t pay it.
- The Deductible: The fixed amount the patient must pay 100% out-of-pocket before their insurance “kicks in.” This is the “January Problem.” A patient with an $8,000 deductible is told on January 2nd that their first fill of the year will cost them $8,000. They will refuse the fill.
- The Copayment: A fixed, flat-dollar amount after the deductible is met. In specialty, this isn’t $20. It’s often a “Tier 5” or “Specialty Tier” copay of $150, $250, or more.
- The Coinsurance: The most dangerous and toxic of all. The patient pays a percentage of the drug’s cost (e.g., 20%, 30%, even 50%). For a $6,000 drug, a 30% coinsurance is $1,800 every single month. This is completely unaffordable and is a primary target for your intervention.
- The Coverage Gap (Medicare “Donut Hole”): We will do a deep dive in the Medicare module, but this is a phase in Medicare Part D where the patient’s cost-share suddenly skyrockets until they reach the “Catastrophic” phase.
Barrier 2.2: The Pharmacist’s Financial Triage Toolkit
You have three primary tools in your toolkit. The most important question you must ask to triage a patient is: “What kind of insurance do you have?” The answer to this question determines which tool you can legally and ethically use.
The Pharmacist’s Financial Triage Flowchart
START: Patient has a high cost-share
CRITICAL QUESTION: What is the patient’s primary insurance?
Commercial / Private
(e.g., from an employer, ACA Marketplace)
Tool 1: Manufacturer Copay Card
Enroll patient in the manufacturer’s copay assistance program (e.g., “Humira Complete”). This “buys down” the copay, often to $0 or $5.
Government-Funded
(e.g., Medicare, Medicaid, Tricare)
Tool 2: 501(c)(3) Foundations
Enroll patient in an independent, non-profit fund (e.g., PAN Foundation, HealthWell) for their specific disease. This is legal because the fund is not tied to one drug.
Uninsured / Underinsured
(e.g., lost job, plan doesn’t cover drug at all)
Tool 3: Manufacturer PAP
Enroll patient in the manufacturer’s “Patient Assistance Program” (PAP). If approved based on income, they will ship the patient the drug for free.
The Anti-Kickback Statute: Your Legal Red Line
This is the most important legal line you must know. Why can’t you use a manufacturer copay card for a Medicare patient?
It is illegal under the federal Anti-Kickback Statute. The government considers it an illegal “inducement” or “kickback” for a manufacturer to pay for a beneficiary’s copay to encourage them to use their specific, expensive drug, which the government (via Medicare) is then paying for. It’s seen as steering the patient away from a cheaper alternative.
This is why the 501(c)(3) independent foundations exist. They are legal because they are “bona fide” charities. They are not tied to any one manufacturer, and they offer aid for a disease state (e.g., “Rheumatoid Arthritis Fund”), not a specific drug. A patient receiving a grant from the PAN Foundation could use it for Humira, Enbrel, or Xeljanz. This independence makes it legal. Your job is to know which funds are open and get your Medicare patients enrolled, often in January before the funds run out.
Masterclass Table: The Financial Assistance Toolkit
| Tool | Tool 1: Copay Card | Tool 2: 501(c)(3) Foundation | Tool 3: Patient Assistance Program (PAP) |
|---|---|---|---|
| Who is it for? | Patients with Commercial insurance. | Patients with Government insurance (Medicare). | Uninsured or “functionally uninsured” (e.g., plan has no coverage, 90-day PA denial). |
| Who provides it? | The drug Manufacturer (e.g., AbbVie, Pfizer). | Independent Charities (e.g., PAN Foundation, HealthWell, GoodDays, LLS). | The drug Manufacturer (e.g., “AbbVie Patient Assistance”). |
| What does it cover? | The patient’s cost-share (copay, coinsurance) *only*. | The patient’s cost-share. Can sometimes also cover insurance premiums. | The entire cost of the drug. They ship the drug for free. |
| How does it work? | You run the primary insurance, then run the copay card as a secondary payer using the BIN/PCN on the card. | Patient gets a “grant” (e.g., $5,000 for the year). You submit claims to the foundation’s portal to draw down from the grant. | A long application (10-20 pages) requiring proof of income (tax returns) and provider signatures. |
| Pharmacist’s Role | The Enroller. Go to the drug’s website, find the “Savings” link, and enroll the patient in 30 seconds. This is your first step for every commercial patient. | The Watchdog. You must know which funds are open (they open and close fast!). Get your patient’s application in ASAP. You are the “quarterback.” | The Advocate. You are the patient’s case manager. You help them gather the paperwork, you get the provider to sign it, and you fax it in. This is a high-touch, high-value intervention. |
11.1.5 Masterclass: Deconstructing Logistical & System Barriers
Logistical barriers (or “system barriers”) are the “friction” and “red tape” of the healthcare system that prevent a ready, willing, and able patient from getting their medication. The patient has done nothing wrong, but the *system* fails them. Your specialty pharmacy experience is defined by your ability to navigate and defeat these system-level barriers. You are the “fixer” who cuts the red tape.
Barrier 3.1: Prior Authorization (PA) and Step-Therapy Hell
This is the most common, most frustrating logistical barrier. The provider prescribes Drug A. The patient’s insurance (the PBM) says, “No. We won’t cover Drug A until the patient has first tried and failed Drug B and Drug C (our preferred, cheaper alternatives).” This is called a “Step-Therapy” protocol.
The patient is now “non-adherent” because they can’t even start the drug. This can lead to a 2-4 week delay in therapy, during which their disease can flare. Your role is to be the expert navigator who pushes the PA through.
Pharmacist Playbook: The 3-Step PA Triage
When a PA is rejected, you don’t just “fax the doctor.” You investigate.
- Step 1: Get the “Why”.
Call the PBM’s pharmacy help desk. Do not use the automated system. Get a human. Ask for the specific reason for rejection.
Script: “Hi, I’m calling for patient Jane Doe, ID 12345. I’m showing a rejection for Xeljanz. Can you please tell me the exact reason? Is it a step-therapy requirement, a quantity limit, or a non-formulary exclusion?”
The Answer: “It is a step-therapy requirement. The patient must try and fail Humira and Enbrel first.” - Step 2: Gather the Evidence.
Now you have your target. You call the prescriber’s office (you are their partner, not their burden).
Script: “Hi, this is [Your Name], the specialty pharmacist for Jane Doe. I’m working on the Xeljanz PA. The insurance is rejecting it, saying she needs to try Humira and Enbrel first. I’m calling to see if we can prove she’s already done this. Can you check her chart for me? Has she ever been on either of those drugs?”
The Answer: “Ah, let me look… Yes, she was on Humira for 6 months in 2022 but developed antibodies and lost response. She’s never been on Enbrel.” - Step 3: Submit the Appeal (or Advise the Provider).
You have your ammunition. You can now help the provider submit a winning appeal. A “standard” appeal just says “Please approve.” A “CASP-level” appeal is a clinical argument.
Winning Appeal Language: “Patient Jane Doe (ID 12345) is prescribed Xeljanz 5mg BID for severe rheumatoid arthritis. This appeal is to bypass the step-therapy requirement for Humira and Enbrel.
– Failure of Humira (Preferred Step 1): Per chart notes (see attached), patient was trialed on Humira from 05/2022 to 11/2022 and lost response due to documented antibody formation.
– Contraindication to Enbrel (Preferred Step 2): Patient has a comorbid diagnosis of Congestive Heart Failure, Class III (see attached echo report). Per the Enbrel package insert, it is relatively contraindicated in moderate-to-severe CHF.
Therefore, the patient has clinically failed or is contraindicated to both preferred agents, and Xeljanz is the next appropriate, medically necessary therapy.”
Barrier 3.2: Cold Chain & Delivery Logistics
Most biologics and specialty drugs are “cold chain” products. They must be refrigerated from the moment they are made until the moment the patient injects them. This creates a chain of potential failure points. A single mistake—a delayed FedEx truck, a patient not home for a delivery, a package left on a hot porch, a power outage—can destroy a $15,000 shipment of medication.
Pharmacist Playbook: The Cold Chain Patient Checklist
During your adherence calls, you must proactively manage the delivery logistics. This is a non-negotiable part of specialty dispensing.
1. The “Delivery Day” Confirmation Script:
Script: “Hi Mrs. Jones, this is [Your Name] from the pharmacy. I’m calling to schedule your next shipment of Enbrel. We are required to send this ‘signature required’ via FedEx Priority Overnight in a cold-chain cooler. We are planning to ship it next Tuesday, October 28th, for delivery on Wednesday, October 29th. Can you please confirm that you or another adult will be home all day on Wednesday the 29th to sign for this package?”
2. The “What-If” Plan:
Script: “What if you miss the delivery? FedEx will not leave the package. They will re-attempt the next day. The cooler is only rated for 48 hours. If you miss them on Wednesday, you must call us so we can try to have it held at the FedEx facility for you to pick up. If not, the drug may get too warm and we’ll have to discard it.”
3. The “Travel” Plan:
Script: “I see you’re going on vacation next month. This is very important. You cannot put your medication in your checked luggage. The cargo hold freezes and will destroy the drug. You must carry it on the plane with you in a hand-held cooler. We can provide you with a travel cooler and a letter for TSA explaining that this is a medically necessary liquid. Do you need me to get that ready for you?”
4. The “What’s In the Box” Education:
Script: “When you receive your box, please open it immediately. Inside you will find the medication and several frozen gel packs. The medication should feel cool, but not frozen. If the medicine itself is frozen solid, do not use it. Call me immediately. If it’s cool, take the medicine and put it directly into your refrigerator. Do not put it in the freezer.”
Barrier 3.3: REMS (Risk Evaluation and Mitigation Strategies)
REMS programs are high-friction, FDA-mandated safety protocols for drugs with significant risks. These programs create massive logistical hurdles where a single missed “checkbox” stops a fill cold. Your job as the pharmacist is to be the REMS gatekeeper and coordinator. You are the central hub ensuring the patient, provider, and pharmacy are all in compliance.
Masterclass Table: Navigating Common REMS Programs
| Drug / Program | Risk Being Mitigated | The Logistical Barrier | The CASP Pharmacist’s Actionable Role |
|---|---|---|---|
| Isotretinoin (iPLEDGE) (Accutane) |
Severe teratogenicity (birth defects). | Patient, provider, and pharmacy must all be registered. Female patients must have 2 negative pregnancy tests, be on 2 forms of birth control, and answer monthly questions. Pharmacy has a 7-day window from the pregnancy test to dispense. | You are the “window” manager. You must check the iPLEDGE system to see the “Dispense By” date. You must call the patient on day 1: “Your window is open. You must pick this up by [date] or the system will lock us out.” |
| Clozapine (Clozapine REMS) (Schizophrenia) |
Severe neutropenia (low white blood cells). | Patient must have their Absolute Neutrophil Count (ANC) checked weekly, then bi-weekly, then monthly. The provider must upload the ANC to the central registry. | You cannot dispense until you log in to the REMS registry and see a “green light” (a current, acceptable ANC). If it’s “red,” you must call the provider: “Dr. Smith, I cannot fill the clozapine for John Doe. The REMS registry is missing his ANC for this week.” |
| Natalizumab (Tysabri TOUCH) (Multiple Sclerosis) |
Progressive Multifocal Leukoencephalopathy (PML), a rare brain infection. | Provider and patient must be registered. Patient must be re-educated on PML risk every 6 months. An authorization number is required for every single infusion. | (As the infusion pharmacist) You must log in to the TOUCH registry *before every infusion*, verify the patient’s authorization is active, and complete the “Pre-Infusion Checklist.” This is a hard stop. |
| TIRF Products (e.g., Subsys, Actiq) (Transmucosal Fentanyl for Cancer Pain) |
Misuse, abuse, overdose, and diversion. | Patient, provider, and pharmacy must all be enrolled. Patient must sign a patient-provider agreement. | You must verify enrollment for both patient and provider in the REMS database before dispensing. You are the final checkpoint for ensuring this is not being diverted or misused. |
11.1.6 Masterclass: Deconstructing Psychosocial Barriers
Psychosocial barriers are the “human” factors. They are the patient’s internal emotional state (psycho-) and their external living situation (-social). This domain is often the most overlooked—and the most difficult to solve. You cannot fix a patient’s depression with a copay card. You cannot solve a lack of social support with a better delivery schedule. This is where your skills as an empathetic listener, a trusted partner, and a resource coordinator become paramount.
Barrier 4.1: Mental Health & Comorbidities (Depression, Anxiety, “Brain Fog”)
This is a vicious cycle. The chronic, debilitating nature of a specialty disease (e.g., RA, Psoriasis, MS, Crohn’s) is a primary driver of depression and anxiety. In turn, that depression robs the patient of the energy, motivation, and executive function required to manage their complex illness. This is called “adherence fatigue.”
Furthermore, some specialty drugs (e.g., older interferons, high-dose steroids) can *cause* depression or psychosis as a side effect. And many conditions, like Multiple Sclerosis, cause cognitive impairment (“brain fog”), which is a *clinical* barrier (they forget) and a *psychosocial* one (they are too frustrated and overwhelmed to try).
Pharmacist Playbook: Screening for Depression
You are often the healthcare provider who speaks to the patient most frequently. You are in a unique position to spot the warning signs of depression. You are not a psychiatrist, but you are a “first-alert” system. When a patient sounds hopeless, flat, or consistently “fatigued,” you can deploy a simple, validated screening tool.
The PHQ-2 Screen (Patient Health Questionnaire-2):
Script: “Mrs. Smith, I know we’re talking about your medication, but I’ve noticed you sound pretty down the last few times we’ve spoken. I just want to check in, because this illness is a heavy burden. Would you mind if I ask you two quick questions?”
1. “Over the past two weeks, how often have you been bothered by little interest or pleasure in doing things?” (Not at all, Several days, More than half the days, or Nearly every day)
2. “Over the past two weeks, how often have you been bothered by feeling down, depressed, or hopeless?” (Not at all, Several days, More than half the days, or Nearly every day)
Your Action: A score of 3 or more (where “More than half the days” = 2) is a positive screen. This does *not* diagnose depression, but it’s a red flag.
Script: “Thank you for sharing that. It sounds like you’re carrying a really heavy load right now, and you are not alone in this. This is a very common part of managing a chronic illness. I am going to make two calls for you right now. The first is to your doctor, just to let them know what’s going on. The second is to our social work team, to see if we can get you connected with some support resources. Would that be okay with you?”
Barrier 4.2: Lack of Social Support (Caregiver Burnout)
Many specialty patients cannot manage their own care. This includes:
– Pediatric patients: The “patient” is actually the parents, who must navigate school, work, and a complex medication schedule.
– Geriatric patients: An elderly patient with severe RA may be physically unable to use an auto-injector pen due to their own arthritis.
– Cognitively impaired patients: An MS patient with severe brain fog may rely entirely on their spouse.
In these cases, your “patient” is the caregiver. And that caregiver is often exhausted, untrained, and overwhelmed. This “caregiver burnout” is a direct adherence barrier. The caregiver is the one who forgets the dose, misses the delivery, or can’t fight the PA.
Pharmacist Playbook: Identifying and Supporting the Caregiver
During your adherence calls, you must identify who is *actually* responsible for the medication and direct your interventions to them.
Case Study: You are calling for Mr. Jones, an 82-year-old with RA, about his Enbrel injector. His wife, 79, answers the phone.
You: “Hi, I’m calling for Mr. Jones about his Enbrel. Is he available?”
Wife: “Oh, honey, he can’t come to the phone. I handle all his medicines. To be honest, I’m… I’m just so tired. I’m scared to give him this shot. My hands shake.”
Pharmacist Intervention: You have identified the *real* barrier. The patient doesn’t have a needle phobia; the *caregiver* does, and she also has a *clinical* barrier (shaky hands).
Script: “Mrs. Jones, thank you so much for telling me that. It sounds like you are doing an amazing job under a lot of stress. Let’s solve this together.
1. Solve the Clinical Barrier: The standard Enbrel auto-injector has a small button that can be hard to press. But did you know they make one called the ‘Enbrel AutoTouch’? It has a wide, ergonomic grip and a button that is much easier for hands with arthritis. I’m going to call the doctor right now and ask for a prescription for that specific device.
2. Solve the Fear Barrier: That new device will help, but I also want you to feel confident. We have a nurse educator who can come to your house and do a ‘First Dose Teach’ with you, just like we discussed earlier.
3. Solve the Burnout Barrier: You are handling a lot. Does your husband have a home health aide, or are you doing this all yourself? Let me connect you with our social worker, who can link you with local ‘respite care’ services, which can give you a break for a few hours a week.”
Barrier 4.3: Social Stigma and Cultural Factors
The disease itself can be a source of shame, leading patients to hide their illness and their medication. This is particularly true for conditions like:
- HIV/AIDS: The patient may not want their family or partner to know, so they hide their medication, skip doses, and risk treatment failure.
- Severe Psoriasis: The patient is embarrassed by their skin and feels “unclean,” leading to depression and a sense of fatalism (“Why bother?”).
- Mental Health (e.g., Schizophrenia): The patient feels branded by their diagnosis and may stop their long-acting injectable to “prove” they aren’t “crazy.”
Cultural beliefs can also play a major role. A patient may have a deep-seated distrust of “Western medicine,” or a strong belief in herbal/natural remedies, or a fatalistic worldview that “this is God’s will” and the medicine is interfering.
Your Role: You are not a theologian or a sociologist. You are a non-judgmental, trusted healthcare professional. Your job is to seek to understand, not to judge. You must use the communication techniques we will master in Section 11.2, like Motivational Interviewing.
Wrong Approach (Judgmental): “You can’t take that herbal supplement, it’s dangerous! You have to take your medicine.”
Right Approach (Seeking to Understand): “I’m curious, can you tell me more about the herbal remedy your aunt recommended? What have you heard about it?… Thank you for sharing that. It sounds like you’re trying to find the most natural, healthy way to manage this. Let’s talk about how we can make your prescribed therapy a safe part of that goal.”
11.1.7 Masterclass: Deconstructing Behavioral & Health Literacy Barriers
Behavioral barriers are about the patient’s knowledge, beliefs, and habits. This domain covers everything from simple forgetfulness to a complex web of misinformation consumed on social media. This is where your role as an Educator and “Myth-Buster” is most critical. A patient cannot adhere to a plan they do not understand or do not believe in.
Barrier 5.1: Low Health Literacy
Health Literacy is not “intelligence.” It is a patient’s ability to find, understand, and use health information to make decisions. The CDC estimates that 9 out of 10 adults struggle with health literacy. Many patients—even highly educated ones—do not understand the complex language of medicine. They are confused by terms like “autoimmune,” “biologic,” “deductible,” and “viral load.”
When a patient doesn’t understand what their drug is, why they are taking it, or how to use it, they will not be adherent. They will nod and smile in the doctor’s office because they are embarrassed to ask questions, and then go home and do it all wrong—or not at all.
Pharmacist Playbook: The “Teach-Back” Method
This is the single most effective tool to combat low health literacy. It is the core of all good patient education. You are *not* “quizzing” the patient. You are checking how well *you* did at explaining the concept.
The “Teach-Back” Setup:
Script: “Mr. Brown, I know this is a lot of information, and I want to make sure I did a good job explaining it. In your own words, can you just tell me…
– …what is this medicine treating?
– …how are you going to take it?
– …and what is the one side effect you’re going to watch out for?”
Listen to the Answer:
If the patient says, “I’m taking this for my… (looks at bottle)… Crotch’s disease… I think? And I… I’m not sure, I think I take it when I feel bad?”
You have failed. But you have also *succeeded*, because you have identified a massive adherence barrier that would have gone unnoticed.
Your Response (No Shame, Re-Educate):
Script: “That’s my fault. I used too much medical jargon. Let’s try again, much simpler.
1. This drug is for your Crohn’s disease. Think of it as a ‘fire extinguisher’ for the inflammation in your intestines.
2. You must take it every single day, even when you feel good. This drug is what keeps you feeling good. It’s for prevention.
3. The main thing to watch for is any sign of an infection, like a fever. If you get one, just call us before taking your next dose.
Okay, let’s try that one more time. Just so I know I’m being clear, what’s this ‘fire extinguisher’ for?”
Barrier 5.2: Misinformation and Patient Beliefs
Your patients are drowning in misinformation. They are on Facebook groups, TikTok, and blogs where they are exposed to terrifying (and false) information. They will see “Black Box Warnings” (e.g., risk of lymphoma for biologics) and misinterpret the risk. They will hear from an influencer that a “celery juice diet” can cure their MS. This is not a “literacy” problem; this is a “belief” problem.
Pharmacist Playbook: The “Myth-Buster” (using Motivational Interviewing)
You cannot win by “lecturing” or “debunking.” This makes the patient defensive. You must validate their concern, ask permission, and provide data in a non-threatening way.
Patient says: “I’m stopping my Humira. I read online that it causes cancer, and I’m not going to poison myself.”
The Wrong Response: “That’s ridiculous. The risk is tiny. You’re more likely to end up in the hospital from your Crohn’s.” (You just shamed them and lost their trust).
The CASP Response (Validate, Ask, Provide):
1. Validate: “Thank you for telling me that. That sounds terrifying, and it makes perfect sense why you would want to stop. You are absolutely right to be concerned about safety.”
2. Ask Permission: “I’ve spent a lot of time looking at the clinical studies on this. Would it be okay if I shared what I’ve found, just so you have all the information?”
3. Provide (with perspective): “You are right, the FDA has a warning about lymphoma. When they studied thousands of patients, they found the risk was about 2 in 10,000 patients per year. That’s a 0.02% chance.
…But what the studies also found is that patients with severe, active Crohn’s disease… their risk of getting lymphoma is *also* higher than normal, even without the drug, because the body is so inflamed.
…The risk of not taking the drug—like having a bowel perforation, needing surgery, or getting colon cancer from the untreated inflammation—is much, much higher.
My job is to help you weigh this. It’s a very small risk of lymphoma versus a very large, very real risk of your disease getting worse. Given that, what are your thoughts?”
Barrier 5.3: Simple Forgetfulness (The “Oops” Barrier)
Finally, we have the most common and human barrier of all: patients just forget. Their lives are busy. They have kids, jobs, and a thousand other things to think about. An oral specialty drug taken twice a day is easy to miss. A once-a-month injection is so infrequent, it’s even easier to forget.
Your Role: The “Adherence Coach.” You must help the patient build the medication into their life. This is where your community pharmacy skills shine brightest.
- For Daily Meds:
– Habit Stacking: “Where can we ‘stack’ this habit? Do you brush your teeth every morning? Great. Let’s put a pill box right next to your toothbrush. You can’t brush your teeth without seeing your pill.”
– Pill Boxes: Proactively recommend and provide multi-dose pill organizers.
– Phone Alarms: “Let’s set a recurring alarm on your phone right now, together. What time works best?” - For Infrequent Meds (Injections):
– Calendar Reminders: “This is a once-every-4-weeks shot. Let’s get out your phone calendar. Your first dose is this Friday. Let’s make a ‘Take Fasenra’ appointment for 4 weeks from today, and let’s set a reminder for 1 day before. Now, let’s make that a recurring event.”
– Adherence Apps: Many manufacturers (and your pharmacy) have adherence apps that will send automated reminders.
– Proactive Pharmacy Calls: This is *your* job. “Hi Mr. Patient, this is your adherence call. I see your next injection is due this Friday. This is your reminder to take your pen out of the fridge on Thursday night so it’s ready for you.”
11.1.8 Conclusion: From Barrier Investigator to Solution Architect
As you have seen in this deep dive, non-adherence is rarely a simple, single-point failure. It is almost always a complex “pileup” of multiple, overlapping barriers. The financial problem is tangled up with the logistical problem, which is worsened by the psychosocial problem.
A standard pharmacist identifies one barrier. An Advanced Specialty Pharmacist assumes there are *at least* two. Your new role is to be a Solution Architect. You must use this 5-pillar framework on every patient call to rapidly investigate, triage, and build a comprehensive solution plan.
In the next section, we will build on this foundation. Now that you can identify the barriers, we will master the communication strategies—like motivational interviewing and shared decision-making—that you need to actually solve them in a respectful, patient-centered way.
